A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma

Figure 5

Validation of UMPS in the TCGA cohort. (a) Risk score distribution. (b) Survival overview. (c) Survival curve of UMPS for metastasis-free survival. The high-risk group had worse metastasis-free survival than the low-risk group. (d, e) Time-dependent receiver operating characteristic (ROC) analysis for comparing the performance of UMPS and the clinicopathological factors. The AUC of UMPS was higher than the single clinicopathological factor in predicting 3-y and 5-y metastasis-free survival. The addition of UMPS could improve the performance of the AJCC TNM staging system.

(a)

(b)

(c)

(d)

(e)